Device Trial Radar · NCT06651775
Effectiveness of High Intensity Laser Therapy (HILT) in Patients With Chronic Lumbar Radiculopathy Due to Disc Herniation.
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
70
Actual
Start
May 15, 2024
Primary completion
Jan 15, 2025
Study completion Feb 15, 2025
Sponsor
- Lead sponsor
- Ankara City Hospital BilkentAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Oct 22, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of the researchers in this intervention study was to see the effects of High Intensity Laser Therapy (HILT) on participants' disability, functionality and pain parameters in chronic radicular low back pain due to lumbar disc herniation, and to investigate its superiority over widely used conventional electrotherapy modalities. The main question it aims to answer is: What is the short and long term effect of high intensity laser therapy on low back and leg pain in patients with chronic lumbar radiculopathy due to disc herniation? 35 patients in group A will receive the planned Hotpack, TENS, High Intensity Laser Therapy (HILT) and exercise treatments for lumbar radicular low back pain. In group B (comparison group) 35 patients will receive Hotpack, TENS, sham HILT, and exercise treatments. Participants will receive 15 sessions of treatment and exercises will be given as a home program. Both groups will complete questionnaires about disability, life functions and pain before and after treatment and at the 3rd month follow-up.
Conditions
- Lumbar Radiculopathy
Interventions
High intensity laser therapyDevice
lumbosciatalgia mode of the HILT device
Sham ComparatorDevice
sham mode of the HILT device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Visual Analogue Scale (VAS)Time frame: pre-treatment, immediately post-treatment and three months follow-up
- Revised Oswestry Disability Index (ODI)Time frame: pre-treatment, immediately post-treatment and three months follow-up
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ankara Bilkent City Hospital
Ankara, Cankaya, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.